Healthcare -
Biotechnology - NASDAQ - US
$ 1.8267
-4.86 %
$ 19.6 M
Market Cap
-1.71
P/E
MRKR - CASH & EQUIVALENTS
Cash & Equivalents MRKR - Marker Therapeutics, Inc.
15.1 M
LAST VALUE
-40.27%
2 YEAR CAGR
-24.54%
5 YEAR CAGR
77.53%
10 YEAR CAGR